在患有肝功能障碍的新生儿中,经过二氧化给药后观察到肝功能障碍:一个病例报告
Hani Ajrina Zulkeflee1, Nur Atiqah Zulkefli2, Aliyyah Mohammad Khuzaini1,3
1Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia, Nilai, Malaysia.
Journal of neonatal-perinatal medicine
|March 19, 2025
概括
用于新生儿低血糖症的氧化物可能会导致肝损伤. 这一案例凸显了新生儿肝脏问题需要谨慎处理的必要性,以及对二氧化的进一步研究.
科学领域:
- 新生儿医学 新生儿医学
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 氧化是新生儿低血糖症的第一线治疗方法,抑制胰岛素分泌.
- 肝酶升高和黄不是通常报告的二氧化的副作用.
研究的目的:
- 报告一个新生儿患有耐火性低血糖症的氧化物诱导的肝损伤病例.
- 讨论在肝功能受损的新生儿中使用二氧化的潜在影响.
主要方法:
- 一个女婴患有耐火性低血糖症的病例报告.
- 在服用二氧化和停止治疗后,对肝酶水平和黄的临床观察.
主要成果:
- 婴儿在服用氧化物后出现肝酶升高和黄恶化.
- 停用二氧化导致肝酶水平的快速改善.
结论:
- 氧化物可能会引起肝毒性,特别是在患有肝功能障碍的新生儿中.
- 需要进行进一步的研究,以了解机制,并制定用于易受伤害的新生儿使用二氧化的指导方针.
相关概念视频
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
127
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
127
Drug Metabolism: Phase I Reactions
2.9K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
2.9K
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
Carboxylic Acids to Methylesters: Alkylation using Diazomethane
2.1K
Carboxylic acids react with diazomethane in an ether solventÃÂÃÂ via alkylation at the carboxylate oxygen atomÃÂÃÂ to giveÃÂÃÂ methyl esters of the corresponding acid with excellent yields.
2.1K
Drug Elimination: Non-Renal Routes
2.3K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.3K


